The Psoriasis Drugs market is expected to grow from an estimated USD 19.65 billion in 2024 to USD 52.34 billion in 2033, at a CAGR of 11.50%. One of the primary causes driving the tremendous demand for safe and effective psoriasis therapies is the disease's increasing global prevalence. According to National Psoriasis Foundation data published in 2023, more than eight million people in the...